Authors:
LOVEJOY DA
AUBRY JM
TURNBULL A
SUTTON S
POTTER E
YEHLING J
RIVIER C
VALE WW
Citation: Da. Lovejoy et al., ECTOPIC EXPRESSION OF THE CRF-BINDING PROTEIN - MINOR IMPACT ON HPA AXIS REGULATION BUT INDUCTION OF SEXUALLY DIMORPHIC WEIGHT-GAIN, Journal of neuroendocrinology, 10(7), 1998, pp. 483-491
Authors:
LODDICK SA
LIU XJ
LU ZX
LIU CL
BEHAN DP
CHALMERS DC
FOSTER AC
VALE WW
LING N
DESOUZA EB
Citation: Sa. Loddick et al., DISPLACEMENT OF INSULIN-LIKE GROWTH-FACTORS FROM THEIR BINDING-PROTEINS AS A POTENTIAL TREATMENT FOR STROKE, Proceedings of the National Academy of Sciences of the United Statesof America, 95(4), 1998, pp. 1894-1898
Authors:
BILEZIKJIAN LM
TURNBULL AV
CORRIGAN AZ
BLOUNT AL
RIVIER CL
VALE WW
Citation: Lm. Bilezikjian et al., INTERLEUKIN-1-BETA REGULATES PITUITARY FOLLISTATIN AND INHIBIN ACTIVIN BETA(B) MESSENGER-RNA LEVELS AND ATTENUATES FSH-SECRETION IN RESPONSE TO ACTIVIN-A/, Endocrinology, 139(7), 1998, pp. 3361-3364
Citation: Mh. Perrin et al., THE FIRST EXTRACELLULAR DOMAIN OF CORTICOTROPIN-RELEASING FACTOR-R1 CONTAINS MAJOR BINDING DETERMINANTS FOR UROCORTIN AND ASTRESSIN, Endocrinology, 139(2), 1998, pp. 566-570
Authors:
HOLMBERG BJ
MORRISON CD
DANIEL JA
BOLDEN OU
GAZAL OS
VALE WW
KEISLER DH
Citation: Bj. Holmberg et al., RESPONSE OF THE REPRODUCTION - NUTRITION AXIS IN OVARIECTOMIZED EWES TO INTRACEREBROVENTRICULAR INFUSION OF UROCORTIN, Biology of reproduction, 58, 1998, pp. 210-210
Authors:
GADDYKURTEN D
COKER JK
VAUGHAN JM
VALE WW
JILKA RL
MANOLAGAS SC
Citation: D. Gaddykurten et al., ATTENUATION OF OSTEOBLASTOGENESIS IN THE MURINE BONE-MARROW BY INHIBIN AND FOLLISTATIN - EVIDENCE FOR DISTINCT EFFECTS AT DIFFERENT STAGES OF THE PROCESS, Journal of bone and mineral research, 12, 1997, pp. 316-316
Authors:
HEINRICHS SC
MIN H
TAMRAZ S
CARMOUCHE M
BOEHME SA
VALE WW
Citation: Sc. Heinrichs et al., ANTISEXUAL AND ANXIOGENIC BEHAVIORAL CONSEQUENCES OF CORTICOTROPIN-RELEASING FACTOR OVEREXPRESSION ARE CENTRALLY MEDIATED, Psychoneuroendocrinology, 22(4), 1997, pp. 215-224
Citation: Jj. Lebrun et Ww. Vale, ACTIVIN AND INHIBIN HAVE ANTAGONISTIC EFFECTS ON LIGAND-DEPENDENT HETEROMERIZATION OF THE TYPE-I AND TYPE-II ACTIVIN RECEPTORS AND HUMAN ERYTHROID-DIFFERENTIATION, Molecular and cellular biology, 17(3), 1997, pp. 1682-1691
Authors:
TSUCHIDA K
SAWCHENKO PE
NISHIKAWA SI
VALE WW
Citation: K. Tsuchida et al., MOLECULAR-CLONING OF A NOVEL TYPE-I RECEPTOR SERINE THREONINE KINASE FOR THE TGF-BETA SUPERFAMILY FROM RAT-BRAIN/, Molecular and cellular neurosciences, 7(6), 1996, pp. 467-478
Authors:
HEINRICHS SC
STENZELPOORE MP
GOLD LH
BATTENBERG E
BLOOM FE
KOOB GF
VALE WW
PICH EM
Citation: Sc. Heinrichs et al., LEARNING IMPAIRMENT IN TRANSGENIC MICE WITH CENTRAL OVEREXPRESSION OFCORTICOTROPIN-RELEASING FACTOR, Neuroscience, 74(2), 1996, pp. 303-311
Authors:
HEINRICHS SC
LAPSANSKY J
BEHAN DP
CHAN RKW
SAWCHENKO PE
LORANG M
LING N
VALE WW
DESOUZA EB
Citation: Sc. Heinrichs et al., CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN LIGAND INHIBITOR BLUNTS EXCESSIVE WEIGHT-GAIN IN GENETICALLY-OBESE ZUCKER RATS AND RATS DURING NICOTINE WITHDRAWAL, Proceedings of the National Academy of Sciences of the United Statesof America, 93(26), 1996, pp. 15475-15480
Authors:
GRIGORIADIS DE
LIU XJ
VAUGHN J
PALMER SF
TRUE CD
VALE WW
LING N
DESOUZA EB
Citation: De. Grigoriadis et al., I-125 TYR(0)-SAUVAGINE - A NOVEL HIGH-AFFINITY RADIOLIGAND FOR THE PHARMACOLOGICAL AND BIOCHEMICAL-STUDY OF HUMAN CORTICOTROPIN-RELEASING FACTOR(2-ALPHA) RECEPTORS, Molecular pharmacology, 50(3), 1996, pp. 679-686
Authors:
POZZOLI G
BILEZIKJIAN LM
PERRIN MH
BLOUNT AL
VALE WW
Citation: G. Pozzoli et al., CORTICOTROPIN-RELEASING FACTOR (CRF) AND GLUCOCORTICOIDS MODULATE THEEXPRESSION OF TYPE-1 CRF RECEPTOR MESSENGER-RIBONUCLEIC-ACID IN RAT ANTERIOR-PITUITARY CELL-CULTURES, Endocrinology, 137(1), 1996, pp. 65-71
Authors:
BEHAN DP
CEPOI D
FISCHER WH
PARK M
SUTTON S
LOWRY PJ
VALE WW
Citation: Dp. Behan et al., CHARACTERIZATION OF A SHEEP BRAIN CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN (VOL 709, PG 265, 1996), Brain research, 732(1-2), 1996, pp. 267-267
Authors:
BEHAN DP
CEPOI D
FISCHER WH
PARK M
SUTTON S
LOWRY PJ
VALE WW
Citation: Dp. Behan et al., CHARACTERIZATION OF A SHEEP BRAIN CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN, Brain research, 709(2), 1996, pp. 265-274
Authors:
LOVEJOY DA
CORRIGAN AZ
NAHORNIAK CS
PERRIN MH
PORTER J
KAISER R
MILLER C
PANTOJA D
CRAIG AG
PETER RE
VALE WW
RIVIER JE
SHERWOOD NM
Citation: Da. Lovejoy et al., STRUCTURAL MODIFICATIONS OF NONMAMMALIAN GONADOTROPIN-RELEASING-HORMONE (GNRH) ISOFORMS - DESIGN OF NOVEL GNRH ANALOGS, Regulatory peptides, 60(2-3), 1995, pp. 99-115
Authors:
BEHAN DP
DESOUZA EB
LOWRY PJ
POTTER E
SAWCHENKO P
VALE WW
Citation: Dp. Behan et al., CORTICOTROPIN-RELEASING FACTOR (CRF) BINDING-PROTEIN - A NOVEL REGULATOR OF CRF AND RELATED PEPTIDES, Frontiers in neuroendocrinology, 16(4), 1995, pp. 362-382
Citation: D. Gaddykurten et Ww. Vale, ACTIVIN INCREASES PHOSPHORYLATION AND DECREASES STABILITY OF THE TRANSCRIPTION FACTOR PIT-1 IN MTTW15 SOMATOTROPE CELLS, The Journal of biological chemistry, 270(48), 1995, pp. 28733-28739
Authors:
SUTTON SW
BEHAN DP
LAHRICHI SL
KAISER R
CORRIGAN A
LOWRY P
POTTER E
PERRIN MH
RIVIER J
VALE WW
Citation: Sw. Sutton et al., LIGAND REQUIREMENTS OF THE HUMAN CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN, Endocrinology, 136(3), 1995, pp. 1097-1102
Authors:
TSUCHIDA K
VAUGHAN JM
WIATER E
GADDYKURTEN D
VALE WW
Citation: K. Tsuchida et al., INACTIVATION OF ACTIVIN-DEPENDENT TRANSCRIPTION BY KINASE-DEFICIENT ACTIVIN RECEPTORS, Endocrinology, 136(12), 1995, pp. 5493-5503
Authors:
STERN CD
YU RT
KAKIZUKA A
KINTNER CR
MATHEWS LS
VALE WW
EVANS RM
UMESONO K
Citation: Cd. Stern et al., ACTIVIN AND ITS RECEPTORS DURING GASTRULATION AND THE LATER PHASES OFMESODERM DEVELOPMENT IN THE CHICK-EMBRYO, Developmental biology, 172(1), 1995, pp. 192-205